Eventide Asset Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-8,600
| Closed | -$1.17M | – | 146 |
|
|
2017
Q4 | $1.17M | Sell |
8,600
-4,600
| -35% | -$626K | 0.06% | 122 |
|
|
2017
Q3 | $2.14M | Hold |
13,200
| – | – | 0.12% | 103 |
|
|
2017
Q2 | $1.98M | Hold |
13,200
| – | – | 0.12% | 97 |
|
|
2017
Q1 | $2.06M | Hold |
13,200
| – | – | 0.14% | 92 |
|
|
2016
Q4 | $2.75M | Hold |
13,200
| – | – | 0.18% | 87 |
|
|
2016
Q3 | $3.02M | Hold |
13,200
| – | – | 0.18% | 84 |
|
|
2016
Q2 | $2.72M | Hold |
13,200
| – | – | 0.17% | 91 |
|
|
2016
Q1 | $3.35M | Hold |
13,200
| – | – | 0.19% | 86 |
|
|
2015
Q4 | $4.53M | Buy |
13,200
+4,430
| +51% | +$1.52M | 0.23% | 90 |
|
|
2015
Q3 | $2.23M | Buy |
8,770
+2,639
| +43% | +$671K | 0.13% | 97 |
|
|
2015
Q2 | $1.72M | Buy |
+6,131
| New | +$1.72M | 0.09% | 101 |
|